¡Ø Ãß¼® ¿¬ÈÞ ÈÞ¹«¾È³» : 2024³â 9¿ù 16ÀÏ(¿ù) ~ 2024³â 9¿ù 18ÀÏ(¼ö)

½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1481914

¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå

Prefilled Syringes: Global Markets

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 90 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå ±Ô¸ð´Â 2024³â 145¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ Áß 9.5%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2029³â¸»¿¡´Â 228¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯¸® ÇÁ¸®ÇÊµå ½Ã¸°Áö ºÎ¹®Àº 2024³â 110¾ï ´Þ·¯¿¡¼­ °°Àº ±â°£ Áß 9.8%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2029³â¸»¿¡´Â 175¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. Çöó½ºÆ½ ÇÁ¸®ÇÊµå ½Ã¸°Áö ºÎ¹®Àº 2024³â 35¾ï ´Þ·¯¿¡¼­ CAGR 8.6%·Î ÃßÀÌÇϸç, 2029³â¸»¿¡´Â 53¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ¹ý±ÔÁ¦¡¤»óȯ ȯ°æ, Á¦Ç° ÆÄÀÌÇÁ¶óÀÎ, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸÀÇ ºÐ¼®, ½ÃÀå ±Ô¸ðÀÇ ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇص帳´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå Àü¸Á
  • Á¶»ç ¹üÀ§
  • ½ÃÀå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • °³¿ä
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è¿¡¼­ÀÇ °æÀï·Â

Á¦3Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ

Á¦4Àå ±ÔÁ¦¿Í º¸Çè »óȯ »óȲ

  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ¹Ì±¹
  • À¯·´¿¬ÇÕ
  • ÀϺ»
  • Áß±¹
  • »óȯ »óȲ

Á¦5Àå ÇÁ¸®ÇÊµå ½Ã¸°ÁöÀÇ Á¦Ç° ÆÄÀÌÇÁ¶óÀÎ

  • °³¿ä

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®

  • ¼¼ºÐÈ­ ³»¿ª
  • ¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå : ÀçÁúº°
  • ¼¼°è ½ÃÀåÀÇ ±Ô¸ð¡¤¿¹Ãø
  • À¯¸®
  • Çöó½ºÆ½
  • ¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå : ¼³°èº°
  • ¼¼°è ½ÃÀåÀÇ ±Ô¸ð¡¤¿¹Ãø
  • ½Ì±Û è¹ö ÇÁ¸®ÇÊµå ½Ã¸°Áö
  • µà¾ó è¹ö ÇÁ¸®ÇÊµå ½Ã¸°Áö
  • Ä¿½ºÅ͸¶ÀÌÁî ÇÁ¸®ÇÊµå ½Ã¸°Áö
  • ¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå : Ä¡·áº°
  • ¼¼°è ½ÃÀåÀÇ ±Ô¸ð¡¤¿¹Ãø
  • ÀúºÐÀÚ
  • ¸ð³ëŬ·Î³Î Ç×ü
  • ¹é½Å
  • ±âŸ
  • ¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå : ¿ëµµº°
  • ¼¼°è ½ÃÀåÀÇ ±Ô¸ð¡¤¿¹Ãø
  • ´ç´¢º´
  • ¾Ï
  • °¨¿°Áõ
  • ±âŸ
  • Áö¿ªÀû ³»¿ª
  • ¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå : Áö¿ªº°
  • ¼¼°è ½ÃÀåÀÇ ±Ô¸ð¡¤¿¹Ãø
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦7Àå °æÀï Á¤º¸

  • °æÀï ±¸µµ

Á¦8Àå ÇÁ¸®ÇÊµå ½Ã¸°Áö¿¡¼­ÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡

  • ESG : ¼­·Ð
  • ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå¿¡¼­ÀÇ Áö¼Ó°¡´É¼º
  • ȯ°æ¿¡ ´ëÇÑ ¿µÇâ
  • »çȸÀû Ã¥ÀÓ
  • °Å¹ö³Í½º

Á¦9Àå ºÎ·Ï : ¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå

  • Á¶»ç ¹æ¹ý
  • ¾à¾î
  • Àü½Ã
  • ±â¾÷ °³¿ä
  • ARTE CORP.
  • BAXTER
  • BD
  • F. HOFFMANN-LA ROCHE LTD.
  • GERRESHEIMER AG
  • HASELMEIER
  • NIPRO
  • SHL MEDICAL AG
  • STEVANATO GROUP
  • YPSOMED
KSA 24.05.27

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

The global market for glass prefilled syringes is expected to grow from $11.0 billion in 2024 and is projected to reach $17.5 billion by the end of 2029, at a CAGR of 9.8% during the forecast period of 2024 to 2029.

The global market for plastic prefilled syringes is expected to grow from $3.5 billion in 2024 and is projected to reach $5.3 billion by the end of 2029, at a CAGR of 8.6% during the forecast period of 2024 to 2029.

Report Scope

The current report provides detailed information on the market for prefilled syringes. This report analyzes the market trends of prefilled syringes with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024 to 2029) and regional markets for prefilled syringes. This report will highlight prefilled syringes' current and future market potential and a detailed competitive environment analysis. The recent report will cover regulatory scenarios, drivers, restraints and opportunities. The report also covers market projections for 2029 and the market share for key players.

The market scope in this report is segmented into material, type, design and therapeutics. Based on materials, the report covers glass-based and polymer-based prefilled syringes. The market breakdown by type includes conventional and safety-prefilled syringes. The market is segmented based on design into single-chamber prefilled syringes, dual-chamber and customized prefilled syringes. The report reviews small molecules, heparins, vaccines and all other biologics in the therapeutics segment. It reviews the main prefilled syringe applications, which include arthritis, diabetes, cancer and others.

The market has been segmented into significant geographies, including North America, Europe, Asia-Pacific and other world regions. The regional segment will cover a detailed analysis of major countries, including the U.S., Germany, the U.K., France, Japan, China and India. The market value is estimated for 2023, with forecasts for 2024 and 2029.

Report Includes

  • 55 data tables and 29 additional tables
  • An updated review of the global markets for prefilled syringes
  • Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2029, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the current market's size and revenue growth prospects specific to prefilled syringes, along with a market share analysis by material, application, design, therapeutics, and geographic region
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market
  • Assessment of major market drivers and opportunities estimating current and future demand for prefilled syringes, and key enabling technologies, and COVID-19 impact on the prefilled syringes
  • Discussion of key technology developments, latest trends, and other influential factors
  • Coverage of upcoming market opportunities and areas of focus to forecast this market into various segments and sub-segments
  • Insight into recent industry structure, current competitive scenario, R&D activities, and regulatory and legislative issues currently focused on medical industry
  • An analysis of key patents
  • Profiles of the leading players, including Becton Dickinson and Co., Baxter, Gerresheimer AG, Schott Pharma AG & Co. KGaA, and West Pharmaceuticals

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of the Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Porter's Five Forces Analysis
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Potential for New Entrants
  • Threat of Substitutes
  • Competitiveness in the Industry

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities

Chapter 4 Regulatory and Reimbursement Landscape

  • Regulatory Scenario
  • U.S.
  • European Union
  • Japan
  • China
  • Reimbursement Landscape

Chapter 5 Product Pipeline for Prefilled Syringes

  • Overview

Chapter 6 Market Segmentation Analysis

  • Segmentation Breakdown
  • Global Market for Prefilled Syringes, by Material
  • Global Market Size and Forecast
  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes
  • Global Market for Prefilled Syringes, by Design
  • Global Market Size and Forecast
  • Single-Chamber Prefilled Syringes
  • Dual-Chamber Prefilled Syringes
  • Customized Prefilled Syringes
  • Global Market for Prefilled Syringes, by Therapeutics
  • Global Market Size and Forecast
  • Small Molecules
  • Monoclonal Antibodies
  • Vaccines
  • Other Therapeutics
  • Global Market for Prefilled Syringes, by Application
  • Global Market Size and Forecast
  • Diabetes
  • Cancer
  • Infectious Diseases
  • Other Applications
  • Geographic Breakdown
  • Global Market for Prefilled Syringes, by Region
  • Global Market Size and Forecast
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Chapter 7 Competitive Intelligence

  • Competitive Landscape

Chapter 8 Sustainability in Prefilled Syringes: An ESG Perspective

  • Introduction to ESG
  • Sustainability in the Prefilled Syringes Market
  • Environmental Impact
  • Social Responsibility
  • Governance

Chapter 9 Appendix: Global Prefilled Syringes Market

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • ARTE CORP.
  • BAXTER
  • BD
  • F. HOFFMANN-LA ROCHE LTD.
  • GERRESHEIMER AG
  • HASELMEIER
  • NIPRO
  • SHL MEDICAL AG
  • STEVANATO GROUP
  • YPSOMED
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦